Literature DB >> 18782487

Chronic American trypanosomiasis: parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis.

L A Benvenuti1, A Roggério, H F G Freitas, A J Mansur, A Fiorelli, M L Higuchi.   

Abstract

Myocyte diameter, fractional area of collagen, intensity of myocarditis and parasite persistence (explored by immunohistochemistry and PCR) were evaluated in serial sections of endomyocardial biopsies from 29 outpatients with chronic chagasic cardiopathy. The patients, 25 males and four females with a mean (S.D.) age of 43 (9) years, were subsequently followed up for 3-2861 days (median=369 days). During this follow-up, 16 (55%) of the patients died. The biopsies revealed myocarditis in 25 (86%) of the patients and high-grade myocarditis in 14 (56%). Although immunohistochemistry failed to demonstrate Trypanosoma cruzi antigens in any of the samples, five (33%) of the 15 biopsies successfully tested in the PCR-based assay for T. cruzi DNA were found positive, indicating parasite persistence. There was a significant positive association between myocardial parasite persistence and high-grade myocarditis (P=0.014); five (71%) of the seven endomyocardial biopsies with high-grade myocarditis that were successfully tested in the PCR assays showed persistent T. cruzi DNA. The survival time of the patients was not, however, found to be significantly associated with myocardial parasite persistence, any of the morphometric measurements taken, or the presence or intensity of myocarditis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18782487     DOI: 10.1179/136485908X311740

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  29 in total

1.  Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus.

Authors:  María-Jesús Pinazo; Gerard Espinosa; Montserrat Gállego; Paulo Luis López-Chejade; Julio A Urbina; Joaquim Gascón
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

Review 2.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 3.  Chagas Disease in the United States: a Public Health Approach.

Authors:  Caryn Bern; Louisa A Messenger; Jeffrey D Whitman; James H Maguire
Journal:  Clin Microbiol Rev       Date:  2019-11-27       Impact factor: 26.132

Review 4.  Diagnosis and Management of Chagas Cardiomyopathy in the United States.

Authors:  Lillian Benck; Evan Kransdorf; Jignesh Patel
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

5.  Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice.

Authors:  Ester Roffê; Ana Paula M P Marino; Joseph Weaver; Wuzhou Wan; Fernanda F de Araújo; Victoria Hoffman; Helton C Santiago; Philip M Murphy
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

6.  Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity.

Authors:  E C Sabino; A L Ribeiro; T H Lee; C L Oliveira; A B Carneiro-Proietti; A P Antunes; M M Menezes; B M Ianni; V M Salemi; L Nastari; F Fernandes; V Sachdev; D M Carrick; X Deng; D Wright; T T Gonçalez; E L Murphy; B Custer; M P Busch
Journal:  Eur J Heart Fail       Date:  2015-02-10       Impact factor: 15.534

7.  Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy.

Authors:  Denise Mayumi Tanaka; Luciano Fonseca Lemos de Oliveira; José Antônio Marin-Neto; Minna Moreira Dias Romano; Eduardo Elias Vieira de Carvalho; Antonio Carlos Leite de Barros Filho; Fernando Fonseca França Ribeiro; Jorge Mejia Cabeza; Carla Duque Lopes; Camila Godoy Fabricio; Norival Kesper; Henrique Turin Moreira; Lauro Wichert-Ana; André Schmidt; Maria de Lourdes Higuchi; Edécio Cunha-Neto; Marcus Vinícius Simões
Journal:  J Nucl Cardiol       Date:  2018-02-01       Impact factor: 5.952

8.  Trypanosoma cruzi: experimental parasitism in the central nervous system of albino mice.

Authors:  Antonio Morocoima; Grace Socorro; Régulo Avila; Ana Hernández; Solángel Merchán; Diana Ortiz; Gabriela Primavera; José Chique; Leidi Herrera; Servio Urdaneta-Morales
Journal:  Parasitol Res       Date:  2012-08-07       Impact factor: 2.289

Review 9.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23

10.  The role of fat on cardiomyopathy outcome in mouse models of chronic Trypanosoma cruzi infection.

Authors:  Paul Zaki; Elisa Lbc Domingues; Farhad M Amjad; Maiara B Narde; Karolina R Gonçalves; Mirelle L Viana; Heberth de Paula; Wanderson G de Lima; Huan Huang; Maria T Bahia; Philipp E Sherer; Fabiane M Dos Santos; Louis M Weiss; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2020-03-24       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.